2.526 - 2.550 of 34.477
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Henkel Vz. Call 72,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 17,77x
- Analysis
- Meta Platforms Call 810,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 26,60x
- Analysis
- Novo Nordisk Call 525,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,57x
- Analysis
- Novo Nordisk Call 415,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,13x
- Analysis
- Novo Nordisk Call 295,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,60x
- Analysis
- Novo Nordisk Call 305,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,69x
- Analysis
- Novo Nordisk Call 275,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,46x
- Analysis
- Novo Nordisk Call 385,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,94x
- Analysis
- Novo Nordisk Call 465,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,39x
- Analysis
- Novo Nordisk Call 395,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,40x
- Analysis
- Novo Nordisk Call 355,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 3,04x
- Analysis
- Novo Nordisk Call 455,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,46x
- Analysis
- Novo Nordisk Call 325,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,26x
- Analysis
- Novo Nordisk Call 325,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,84x
- Analysis
- Novo Nordisk Call 475,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,94x
- Analysis
- Novo Nordisk Call 365,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,68x
- Analysis
- Novo Nordisk Call 375,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,79x
- Analysis
- Novo Nordisk Call 355,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,59x
- Analysis
- Novo Nordisk Call 435,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,18x
- Analysis
- Novo Nordisk Call 425,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,72x
- Analysis
- Novo Nordisk Call 445,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,40x
- Analysis
- Novo Nordisk Call 495,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 5,09x
- Analysis
- Novo Nordisk Call 345,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,96x
- Analysis
- Novo Nordisk Call 335,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,35x
- Analysis
- Novo Nordisk Call 395,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,95x
- Analysis